Feeds:
Posts
Comments

Search Results for 'Meg Baker'

Volume Seven – Cardiovascular Research Content, Text Mining & Analysis using Machine Learning: Master Glossary across Six Volumes built from Article’s WordClouds

Posted in on December 6, 2023|

Volume Seven An Audio Book Cardiovascular Research Content, Text Mining & Analysis using Machine Learning: Master Glossary across Six Volumes built from Article’s WordClouds Authors and Editors: Dr. Justin D. Pearlman, MD, PhD, FACC Aviva Lev-Ari, PhD, RN Arav Gandhi, aspiring cardiologist, producer of TTS, WordClouds, Glossaries and Audio e-Book, Volume 7   Volume Seven […]

Read Full Post »

Arav Gandhi, Research Assistant 2, Domain Content: Cardiovascular Diseases, Series A – PERSONAL PAGE

Posted in on September 18, 2023|

Arav Gandhi, Research Assistant 2, Domain Content: Cardiovascular Diseases, Series A https://pharmaceuticalintelligence.com/contributors-biographies/research-assistants/arav-gandhi-research-assistant-2-domain-content-cardiovascular-diseases-series-a/ On this PERSONAL PAGE you will record all your Progress first is the most recent Last is the Old records You create a Table with the following Columns: 10/31/23: Volume 1 Article Data and TTS Conversion Chapter Number Article ID Article Title Article […]

Read Full Post »

e-Voices Podcasting by LPBI: Celebrating Podcast #3 in an Audio Library on leading Scientists and Key Opinion Leaders in Biological Sciences

Posted in LPBI Group, e-Scientific Media, DFP, R&D-M3DP, R&D-Drug Discovery, US Patents: SOPs and Team Management on January 9, 2021| Leave a Comment »

e-Voices Podcasting by LPBI: Celebrating Podcast #3 in an Audio Library on leading Scientists and Key Opinion Leaders in Biological Sciences Authors: Aviva Lev-Ari, PhD, RN   2.0 LPBI had published today its third Podcast uploaded to our Cloud at WordPress.com https://pharmaceuticalintelligence.com/audio-podcasts/ Our three podcasts are about the careers of Leaders in Science and Medicine […]

Read Full Post »

Gail S. Thornton, PhD(c), Contributing Editor, Author and Medical Writer, Marketing Communications

Posted in on August 15, 2020|

Gail S. Thornton, PhD(c),  Contributing Editor, Author and Medical Writer, Marketing Communications INACTIVE 12/31/2022 1/27/2021 Selected Projects: 1. Podcast Schedule https://pharmaceuticalintelligence.com/audio-podcasts/ Development Plan for e-VOICES Podcasting, 2019 – 2021* https://pharmaceuticalintelligence.com/audio-podcasts/ Podcast Interviewer INTERVIEWEE(S) Subject Date Audio/Video/ Narrator           Gail S. Thornton Dr. Stephen J. Williams, Dr. Irina Robu & Dr. Aviva […]

Read Full Post »

Glycosylation and its Role in SARS-CoV-2 Viral Pathogenesis

Posted in Biomarkers: Inflammation, COVID-19, Glycosylation and its Role in SARS-CoV-2 Viral Pathogenesis, Mechanisms of infection by SARS-CoV-2, Population Health Management, Genetics & Pharmaceutical, SARS-CoV-2, SARS-CoV-2 Viral Variants on February 15, 2021| Leave a Comment »

Glycosylation and its Role in SARS-CoV-2 Viral Pathogenesis Author: Meg Baker, PhD   N-Glycosylation and COVID19 Glycobiology N-linked glycosylation (NLG) is a complex biosynthetic process that regulates proper folding of proteins through and intracellular transport of proteins to the secretory pathway. This co- and post-translational modification occurs by a series of enzymatic reactions, which results […]

Read Full Post »

Puntos de vista acerca del óxido nítrico en los mecanismos patogénicos

Posted in on June 6, 2022|

    View on Amazon.com https://www.amazon.com/dp/B0BPST4B4N Audio y Texto NEW GENRE Volume One: Perspectives on Nitric Oxide in Disease Mechanisms – Series A: Volume 1 | Leaders in Pharmaceutical Business Intelligence (LPBI) Group https://pharmaceuticalintelligence.com/audio-english-spanish-biomed-e-series/new-genre-audio-english-spanish-series-a-e-books-on-cardiovascular-diseases/new-genre-volume-one-perspectives-on-nitric-oxide-in-disease-mechanisms-series-a-volume-1/   Original Volume One: Perspectives on Nitric Oxide in Disease Mechanisms NEW GENRE Volume One: Perspectives on Nitric Oxide in Disease Mechanisms https://pharmaceuticalintelligence.com/audio-english-spanish-biomed-e-series/new-genre-audio-english-spanish-series-a-e-books-on-cardiovascular-diseases/new-genre-volume-one-perspectives-on-nitric-oxide-in-disease-mechanisms-series-a-volume-1/ […]

Read Full Post »

Top Authors by Number of e-Readers Views as of 2020-06-02

Posted in on February 17, 2019|

Top Authors by Number of e-Readers Views   UPDATED ON June 9, 2020 Top Authors for all days ending 2020-06-02 (Summarized) All time All Time Author Views 2012pharmaceutical 445,444 larryhbern Following 322,959 tildabarliya 64,468 sjwilliamspa Following 61,198 Dror Nir 35,190 Dr. Sudipta Saha Following 33,704 Demet Sag, Ph.D., CRA, GCP Follow 17,972 ritusaxena Following 17,166 […]

Read Full Post »

Knowledge PORTALS System (KPS)

Posted in on May 2, 2020|

Knowledge PORTALS System (KPS) @LPBI Knowledge PORTALS System (KPS) @LPBI is an initiative launched in September 2020 to manage the content creation @LPBI by our Final Improvement Team (FIT) members during the Transition Period that started on March 14, 2020 with the Launch of the Coronavirus Portal to cover eight aspects of the SARS-CoV-2 Pandemic […]

Read Full Post »

Clinical Trial for the Use of Nitric Oxide to Treat Severe COVID-19 Infection

Posted in COVID-19, FDA Regulatory Affairs, Frontiers in Cardiology and Cardiovascular Disorders, Nitric Oxide in Health and Disease, Population Health Management, Population Health Management, Genetics & Pharmaceutical, SARS-CoV-2, Virus Infective Acute Respiratory Syndrome: SARS-CoV on April 14, 2020| Leave a Comment »

Clinical Trial for the Use of Nitric Oxide to Treat Severe COVID-19 Infection Reporter and Curator: Aviva Lev-Ari, PhD, RN   UPDATED 5/26/2020 Virology . 2009 Dec 5;395(1):1-9. doi: 10.1016/j.virol.2009.09.007. Epub 2009 Oct 1. Dual Effect of Nitric Oxide on SARS-CoV Replication: Viral RNA Production and Palmitoylation of the S Protein Are Affected Sara Akerström1, Vithiagaran Gunalan, Choong Tat […]

Read Full Post »

1.0 LPBI – 2012-2020 VISTA

Posted in on February 17, 2019|

2020 VISTA is the Website for LPBI Group’s Ten Health Care Contents Asset Classes prospected for technology ownership transfer and monetization 6/3/2022 We Celebrate TEN Years of Excellence, LPBI Group: 4/2012 – 4/2022 https://pharmaceuticalintelligence.com/2022/04/25/we-celebrate-ten-years-of-excellence-lpbi-group-4-2012-4-2022/   2022 Update from LPBI Group | Leaders in Pharmaceutical Business Intelligence (LPBI) Group https://pharmaceuticalintelligence.com/2022/02/21/update-from-lpbi-group/ 1.0 LPBI IP Asset Class I: […]

Read Full Post »

Next »

%d